Beyond cystic fibrosis transmembrane conductance regulator therapy: a perspective on gene therapy and small molecule treatment for cystic fibrosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beyond cystic fibrosis transmembrane conductance regulator therapy: a perspective on gene therapy and small molecule treatment for cystic fibrosis
Authors
Keywords
-
Journal
GENE THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-12
DOI
10.1038/s41434-019-0092-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium
- (2019) Asha Kumari Patel et al. ADVANCED MATERIALS
- Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR
- (2018) Scott H. Donaldson et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Recent progress in translational cystic fibrosis research using precision medicine strategies
- (2018) Deborah M. Cholon et al. Journal of Cystic Fibrosis
- Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR Technique
- (2018) Michele Marangi et al. Frontiers in Pharmacology
- Tezacaftor for the treatment of cystic fibrosis
- (2018) Marc A. Sala et al. Expert Review of Respiratory Medicine
- Predictive factors for lumacaftor/ivacaftor clinical response
- (2018) Alexandra Masson et al. Journal of Cystic Fibrosis
- VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
- (2018) Dominic Keating et al. NEW ENGLAND JOURNAL OF MEDICINE
- VX-659–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
- (2018) Jane C. Davies et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cystic Fibrosis Gene Therapy: Looking Back, Looking Forward
- (2018) Ashley Cooney et al. Genes
- Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
- (2017) Jennifer L. Taylor-Cousar et al. NEW ENGLAND JOURNAL OF MEDICINE
- New horizons for cystic fibrosis treatment
- (2017) Isabelle Fajac et al. PHARMACOLOGY & THERAPEUTICS
- rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice
- (2016) Dragana Vidović et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Can Cystic Fibrosis Patients Finally Catch a Breath With Lumacaftor/Ivacaftor?
- (2016) EK Schneider et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cystic fibrosis
- (2016) Stacey L. Martiniano et al. CURRENT OPINION IN PEDIATRICS
- Noninvasive Imaging Reveals Stable Transgene Expression in Mouse Airways After Delivery of a Nonintegrating Recombinant Adeno-Associated Viral Vector
- (2016) Dragana Vidović et al. HUMAN GENE THERAPY
- Development of HPLC and LC–MS/MS methods for the analysis of ivacaftor, its major metabolites and lumacaftor in plasma and sputum of cystic fibrosis patients treated with ORKAMBI or KALYDECO
- (2016) Elena K. Schneider et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study
- (2016) Jane C Davies et al. Lancet Respiratory Medicine
- Progress in therapies for cystic fibrosis
- (2016) Kris De Boeck et al. Lancet Respiratory Medicine
- A Phase I/IIa Safety and Efficacy Study of Nebulized Liposome-mediated Gene Therapy for Cystic Fibrosis Supports a Multidose Trial
- (2015) Eric W. F. W. Alton et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Searching for a cure for cystic fibrosis. A 25-year quest in a nutshell
- (2015) Barbara Bosch et al. EUROPEAN JOURNAL OF PEDIATRICS
- Cystic Fibrosis Gene Therapy in the UK and Elsewhere
- (2015) Uta Griesenbach et al. HUMAN GENE THERAPY
- Outcomes Following Gene Therapy in Patients With Severe Wiskott-Aldrich Syndrome
- (2015) Salima Hacein-Bey Abina et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Drug-drug plasma protein binding interactions of ivacaftor
- (2015) Elena K. Schneider et al. JOURNAL OF MOLECULAR RECOGNITION
- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
- (2015) Claire E. Wainwright et al. NEW ENGLAND JOURNAL OF MEDICINE
- New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls
- (2015) Scott C. Bell et al. PHARMACOLOGY & THERAPEUTICS
- Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
- (2015) Eric W F W Alton et al. Lancet Respiratory Medicine
- Targeted Correction and Restored Function of the CFTR Gene in Cystic Fibrosis Induced Pluripotent Stem Cells
- (2015) Ana M. Crane et al. Stem Cell Reports
- The relative frequency of CFTR mutation classes in European patients with cystic fibrosis
- (2014) K. De Boeck et al. Journal of Cystic Fibrosis
- Overcoming the Cystic Fibrosis Sputum Barrier to Leading Adeno-associated Virus Gene Therapy Vectors
- (2014) Benjamin S Schuster et al. MOLECULAR THERAPY
- Some gating potentiators, including VX-770, diminish F508-CFTR functional expression
- (2014) G. Veit et al. Science Translational Medicine
- Potentiator ivacaftor abrogates pharmacological correction of F508 CFTR in cystic fibrosis
- (2014) D. M. Cholon et al. Science Translational Medicine
- Delivery of genes into the CF airway
- (2014) Deborah R Gill et al. THORAX
- One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR/Cas-Mediated Genome Engineering
- (2013) Hui Yang et al. CELL
- Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients
- (2013) Gerald Schwank et al. Cell Stem Cell
- Gene therapy of primary T cell immunodeficiencies
- (2013) Alain Fischer et al. GENE
- Moving forward: cystic fibrosis gene therapy
- (2013) U. Griesenbach et al. HUMAN MOLECULAR GENETICS
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Assessment of F/HN-Pseudotyped Lentivirus as a Clinically Relevant Vector for Lung Gene Therapy
- (2012) Uta Griesenbach et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans
- (2012) F. Candotti et al. BLOOD
- Ivacaftor
- (2012) Pamela B. Davis et al. NATURE REVIEWS DRUG DISCOVERY
- Current Status and Future Directions of Gene and Cell Therapy for Cystic Fibrosis
- (2011) Uta Griesenbach et al. BIODRUGS
- Gene therapy finds its niche
- (2011) Cormac Sheridan NATURE BIOTECHNOLOGY
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toward Gene Therapy for Cystic Fibrosis Using a Lentivirus Pseudotyped With Sendai Virus Envelopes
- (2010) Katsuyuki Mitomo et al. MOLECULAR THERAPY
- Preclinical Safety Evaluation of AAV2-sFLT01— A Gene Therapy for Age-related Macular Degeneration
- (2010) Timothy K MacLachlan et al. MOLECULAR THERAPY
- The Clinical Approach to Lung Disease in Patients with Cystic Fibrosis
- (2009) Brian O'Sullivan et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression
- (2008) Stephen C Hyde et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More